|Title:||COVID-19 vaccines: concerns beyond protective efficacy and safety||Authors:||Lai, Chih-Cheng
|Keywords:||COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern||Issue Date:||5-Jul-2021||Source:||Expert review of vaccines||Abstract:||
Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings.
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.